Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/3631
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYenercag, Mustafa-
dc.contributor.authorArslan, Ugur-
dc.contributor.authorSeker, Onur O.-
dc.contributor.authorDereli, Seckin-
dc.contributor.authorKaya, Ahmet-
dc.contributor.authorDogdus, Mustafa-
dc.contributor.authorOzturk, Cagatay E.-
dc.contributor.authorAkpinar, Cetin K.-
dc.contributor.authorSen, Ahmet-
dc.date.accessioned2023-01-06T12:08:36Z-
dc.date.available2023-01-06T12:08:36Z-
dc.date.issued2021-
dc.identifier.citationYenercag, M., Arslan, U., Seker, OO., Dereli, S., Kaya, A., Dogdus, M., Ozturk, CE., Akpinar, CK., Sen, A. (2021). Evaluation of P-wave dispersion in patients with newly diagnosed coronavirus disease 2019. Journal of Cardiovascular Medicine, 22(3), 197-203.Doi:10.2459/JCM.0000000000001135en_US
dc.identifier.isbn1558-2027-
dc.identifier.isbn1558-2035-
dc.identifier.urihttp://dx.doi.org/10.2459/JCM.0000000000001135-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:000663719300007-
dc.identifier.urihttps://pubmed.ncbi.nlm.nih.gov/33186236-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/3631-
dc.descriptionWoS Categories : Cardiac & Cardiovascular Systems Web of Science Index : Science Citation Index Expanded (SCI-EXPANDED) Research Areas : Cardiovascular System & Cardiology Open Access Designations : Bronzeen_US
dc.description.abstractAim The aim of the current study was to evaluate P-wave dispersion (PWD) as a predictor of atrial fibrillation in patients with newly diagnosed COVID-19. In addition, the relationship between the PWD and inflammation parameters was investigated. Methods A total of 140 newly diagnosed COVID-19 patients and 140 age- and sex-matched healthy individuals were included in the study. The risk of atrial fibrillation was evaluated by calculating the electrocardiographic PWD. C-reactive protein (CRP), white blood cell, neutrophil and neutrophil-to-lymphocyte ratio (NLR) were measured in patients with newly diagnosed COVID-19. Results PWD, white blood cell, NLR and CRP levels were significantly higher in the COVID-19 group than the control group. There was a significant positive correlation between PWD and CRP level (rs = 0.510, P < 0.001) and NLR in COVID-19 group (rs = 0.302, P = 0.001). In their follow-up, 13 (9.3%) patients, 11 of whom were in the ICU, developed new atrial fibrillation. Conclusion Our study showed for the first time in literature that the PWD, evaluated electrocardiographically in patients with newly diagnosed COVID-19, was prolonged compared with normal healthy individuals. A positive correlation was found between PWD, CRP level and NLR. We believe that pretreatment evaluation of PWD in patients with newly diagnosed COVID-19 would be beneficial for predicting atrial fibrillation risk.en_US
dc.language.isoengen_US
dc.publisherLIPPINCOTT WILLIAMS & WILKINS PHILADELPHIAen_US
dc.relation.isversionof10.2459/JCM.0000000000001135en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectINFLAMMATION; INDEXESen_US
dc.subjectatrial fibrillation; coronavirus disease 2019; P-wave dispersion; severe acute respiratory syndrome-coronavirus-2en_US
dc.titleEvaluation of P-wave dispersion in patients with newly diagnosed coronavirus disease 2019en_US
dc.typearticleen_US
dc.relation.journalJOURNAL OF CARDIOVASCULAR MEDICINEen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0002-0933-7852en_US
dc.contributor.authorID0000-0001-8572-3571en_US
dc.identifier.volume22en_US
dc.identifier.issue3en_US
dc.identifier.startpage197en_US
dc.identifier.endpage203en_US
Appears in Collections:Dahili Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.